Lataa...
Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex
Until recently, the neuropsychiatric phenotype of tuberous sclerosis complex (TSC) was presumed to be caused by the structural brain abnormalities and/or seizures seen in the disorder. However, advances in the molecular biology of the disorder have shown that TSC is a mammalian target of rapamycin (...
Tallennettuna:
| Julkaisussa: | Neurotherapeutics |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer-Verlag
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084231/ https://ncbi.nlm.nih.gov/pubmed/20643380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2010.05.001 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|